申请人:PLEXXIKON, INC.
公开号:EP2395004A2
公开(公告)日:2011-12-14
Compounds (III) active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
描述了对蛋白激酶有活性的化合物(III),以及使用此类化合物治疗与蛋白激酶活性异常有关的疾病和病症的方法。